Skewed X-chromosome inactivation in human miscarriages
- Authors: Vasil’ev S.A.1,2, Sazhenova E.A.1, Zhigalina D.I.2, Grigorovich E.I.2, Nikitina T.V.1, Mel’nikov A.A.1, Zhabina E.S.3, Ivanova T.V.3, Evtushenko I.D.3, Lebedev I.N.1,2,3, Tolmacheva E.N.1,2
-
Affiliations:
- Research Institute of Medical Genetics
- National Research Tomsk State University
- Siberian State Medical University of the Russian Ministry of Health
- Issue: Vol 10, No 1 (2016)
- Pages: 55-59
- Section: Article
- URL: https://journals.rcsi.science/1990-519X/article/view/212028
- DOI: https://doi.org/10.1134/S1990519X16010119
- ID: 212028
Cite item
Abstract
The sex ratio in the first trimester of pregnancy shifts toward males due to increased elimination of female embryos. One reason for this phenomenon may be disruption of X chromosome inactivation. In this paper, we have analyzed the nature of the X chromosome inactivation in extraembryonic tissues of induced and spontaneous abortuses with 46,XX karyotype. Both equiprobable and asymmetric inactivation have been found in chorionic cytotrophoblast from spontaneous and induced abortuses. In the extraembryonic mesoderm of the control group of embryos, only equiprobable inactivation has been found, whereas this parameter was shifted in 15% of spontaneous abortions. The highest incidence of the selective inactivation of one of the parent homologues was found in the group with a lack of development of embryos and embryos from women with recurrent miscarriages. One of the reasons for the observed results can be compartmentalization of cells in the blastocyst leading to the nonrandom redistribution of cells and the predominance in the inner mass of cells with an active X chromosome with aberrations incompatible with normal embryonic development.
About the authors
S. A. Vasil’ev
Research Institute of Medical Genetics; National Research Tomsk State University
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
E. A. Sazhenova
Research Institute of Medical Genetics
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
D. I. Zhigalina
National Research Tomsk State University
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
E. I. Grigorovich
National Research Tomsk State University
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
T. V. Nikitina
Research Institute of Medical Genetics
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
A. A. Mel’nikov
Research Institute of Medical Genetics
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
E. S. Zhabina
Siberian State Medical University of the Russian Ministry of Health
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
T. V. Ivanova
Siberian State Medical University of the Russian Ministry of Health
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
I. D. Evtushenko
Siberian State Medical University of the Russian Ministry of Health
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050
I. N. Lebedev
Research Institute of Medical Genetics; National Research Tomsk State University; Siberian State Medical University of the Russian Ministry of Health
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050; Tomsk, 634050
E. N. Tolmacheva
Research Institute of Medical Genetics; National Research Tomsk State University
Author for correspondence.
Email: kate.tolmacheva@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
Supplementary files
